-
Ethos Technologies (LIFE) PT Raised to $33 at Citizens on 'Very Strong 2Q26 Results'
-
Ethos Technologies (LIFE) PT Raised to $35 at Goldman Sachs
-
aTyr Pharma (LIFE) Reports Q2 EPS of $0.53 ; Offers Guidance
-
Not all AI stocks are expensive: BofA spots hidden opportunities in SMID tech
-
William Blair Updates Analyst Conviction List for June 2026, 6 Adds & 5 Removals
-
Short-seller Fuzzy Panda defends Ethos Tech following Bear Cave short: 'dead wrong'
-
Ethos Technologies (NASDAQ: LIFE) mentioned as short at Bear Cave
-
Ethos Technologies (LIFE) PT Raised to $27 at Citizens After Strong Q1 Results
-
Ethos Technologies (LIFE) PT Raised to $28 at BofA Securities
-
Ethos launches ChatGPT app for instant life insurance estimates
-
Goldman Sachs Starts Ethos Technologies (LIFE) at Buy
-
Deutsche Bank Starts Ethos Technologies (LIFE) at Buy
-
BofA Securities Starts Ethos Technologies (LIFE) at Buy
-
William Blair Starts Ethos Technologies (LIFE) at Outperform
-
Goldman Sachs Starts Ethos Technologies (LIFE) at Buy
-
JPMorgan Starts Ethos Technologies (LIFE) at Overweight
-
Barclays Starts Ethos Technologies (LIFE) at Overweight
-
Barclays Starts Ethos Technologies (LIFE) at Overweight
-
Citizens Starts Ethos Technologies (LIFE) at Market Outperform
-
Baird Starts Ethos Technologies (LIFE) at Outperform
-
Baird Starts Ethos Technologies (LIFE) at Outperform
-
Ethos Technologies (LIFE) files for 10.53M share IPO at $18-$20/sh
-
Ethos Technologies (LIFE) files for a proposed Nasdaq IPO
-
Piper Sandler Reiterates Overweight Rating on aTyr Pharma (LIFE)


